March 17, 2020 / 10:27 AM / 12 days ago

BRIEF-Novus Therapeutics Posts Quarterly Loss Per Share $0.32

March 17 (Reuters) - Novus Therapeutics Inc:

* QUARTERLY LOSS PER SHARE $0.32

* NOVUS THERAPEUTICS - DATA FROM FULLY ENROLLED PHASE 2A EFFICACY STUDY IN INFANTS, CHILDREN WITH ACUTE OTITIS MEDIA TO BE ANNOUNCED BY EARLY JUNE 2020

* NOVUS THERAPEUTICS - CO'S CASH AND CASH EQUIVALENTS, INCLUDING CASH RECEIVED FROM WARRANTS, IS EXPECTED TO FUND OPERATIONS THROUGH YEAR END 2020 Source text for Eikon: bit.ly/2x2vf7X Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below